These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. The GerdQ questionnaire and high resolution manometry support the hypothesis that proton pump inhibitor-responsive oesophageal eosinophilia is a GERD-related phenomenon. Savarino EV; Tolone S; Bartolo O; de Cassan C; Caccaro R; Galeazzi F; Nicoletti L; Salvador R; Martinato M; Costantini M; Savarino V Aliment Pharmacol Ther; 2016 Sep; 44(5):522-30. PubMed ID: 27373195 [TBL] [Abstract][Full Text] [Related]
64. Novel impedance-pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro-oesophageal reflux disease according to Lyon Consensus. Ribolsi M; Frazzoni M; Marabotto E; De Carlo G; Ziola S; Maniero D; Balestrieri P; Cicala M; Savarino E Aliment Pharmacol Ther; 2021 Aug; 54(4):412-418. PubMed ID: 34181753 [TBL] [Abstract][Full Text] [Related]
66. Distinguishing the impact of dexlansoprazole on heartburn vs. regurgitation in patients with gastro-oesophageal reflux disease. Peura DA; Pilmer B; Hunt B; Mody R; Perez MC Aliment Pharmacol Ther; 2013 Nov; 38(10):1303-11. PubMed ID: 24118079 [TBL] [Abstract][Full Text] [Related]
67. Persistent Postprandial Regurgitation vs Rumination in Patients With Refractory Gastroesophageal Reflux Disease Symptoms: Identification of a Distinct Rumination Pattern Using Ambulatory Impedance-pH Monitoring. Nakagawa K; Sawada A; Hoshikawa Y; Nikaki K; Sonmez S; Woodland P; Yazaki E; Sifrim D Am J Gastroenterol; 2019 Aug; 114(8):1248-1255. PubMed ID: 31246694 [TBL] [Abstract][Full Text] [Related]
68. [Gastroesophageal reflux disease: clinical and pathophysiological features (part I)]. Corinaldesi R; Salvioli B; Lioce A; Barbara G; Cremon C; Fustini E; Bini L; Cogliandro R; Boschi E; Felicani C; Stanghellini V; De Giorgio R Clin Ter; 2007; 158(1):77-83. PubMed ID: 17405661 [TBL] [Abstract][Full Text] [Related]
70. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo Schey R; Alla SP; Midani D; Parkman HP Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467 [TBL] [Abstract][Full Text] [Related]
71. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024 [TBL] [Abstract][Full Text] [Related]
72. New developments in the pathophysiology of gastro-oesophageal reflux disease (GERD): implications for patient management. Quigley EM Aliment Pharmacol Ther; 2003 Jun; 17 Suppl 2():43-51. PubMed ID: 12786612 [TBL] [Abstract][Full Text] [Related]
73. Partial symptom-response to proton pump inhibitors in patients with non-erosive reflux disease or reflux oesophagitis - a post hoc analysis of 5796 patients. Bytzer P; van Zanten SV; Mattsson H; Wernersson B Aliment Pharmacol Ther; 2012 Oct; 36(7):635-43. PubMed ID: 22860764 [TBL] [Abstract][Full Text] [Related]
74. Diagnostic value of potent acid inhibition in gastro-oesophageal reflux disease. Monés J Drugs; 2005; 65 Suppl 1():35-42. PubMed ID: 16335856 [TBL] [Abstract][Full Text] [Related]
75. Is the proton pump inhibitor test helpful in patients with laryngeal symptoms? Kim JH; Sung IK; Hong SN; Lee SY; Park HS; Shim CS Dig Dis Sci; 2013 Jun; 58(6):1663-7. PubMed ID: 23443492 [TBL] [Abstract][Full Text] [Related]
76. [Therapy of gastroesophageal reflux disease (GERD)]. Storr M Med Monatsschr Pharm; 2011 Dec; 34(12):446-54; quiz 455-6. PubMed ID: 22233024 [TBL] [Abstract][Full Text] [Related]
77. Efficacy of the addition of prokinetics for proton pump inhibitor (PPI) resistant non-erosive reflux disease (NERD) patients: significance of frequency scale for the symptom of GERD (FSSG) on decision of treatment strategy. Miyamoto M; Manabe N; Haruma K Intern Med; 2010; 49(15):1469-76. PubMed ID: 20686276 [TBL] [Abstract][Full Text] [Related]
78. Efficacy of rabeprazole on heartburn symptom resolution in patients with non-erosive and erosive gastro-oesophageal reflux disease: a multicenter study from Japan. Miwa H; Sasaki M; Furuta T; Koike T; Habu Y; Ito M; Fujiwara Y; Wada T; Nagahara A; Hongo M; Chiba T; Kinoshita Y; Aliment Pharmacol Ther; 2007 Jul; 26(1):69-77. PubMed ID: 17555423 [TBL] [Abstract][Full Text] [Related]
79. Pathophysiology and management of gastroesophageal reflux disease. Rohof WO; Hirsch DP; Boeckxstaens GE Minerva Gastroenterol Dietol; 2009 Sep; 55(3):289-300. PubMed ID: 19829285 [TBL] [Abstract][Full Text] [Related]
80. [The role of the traditional surgical procedures for gastroesophageal reflux disease cannot be ignored]. Zhou JH; Tan QY Zhonghua Wai Ke Za Zhi; 2020 Sep; 58(9):672-676. PubMed ID: 32878412 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]